Anil Namboodiripad
Corporate Officer/Principal presso DR. REDDY'S LABORATORIES LIMITED
Profilo
Anil Namboodiripad is currently the Chief Executive Officer at SCRIPT Biosciences, Inc. since 2021.
He is also the Global Head-Proprietary Products at Dr. Reddy's Laboratories Ltd.
since 2016.
Dr. Namboodiripad holds a doctorate degree from The University of Texas at Austin.
Posizioni attive di Anil Namboodiripad
| Società | Posizione | Inizio |
|---|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Corporate Officer/Principal | 01/12/2016 |
Script Biosciences, Inc.
 Script Biosciences, Inc. Packaged SoftwareTechnology Services SCRIPT Biosciences, Inc. develops a genome editing platform. The American company was founded in 2020. Anil Namboodiripad has been the CEO of the company since 2021. | Chief Executive Officer | 01/01/2021 |
Formazione di Anil Namboodiripad
| The University of Texas at Austin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
Script Biosciences, Inc.
Script Biosciences, Inc. Packaged SoftwareTechnology Services SCRIPT Biosciences, Inc. develops a genome editing platform. The American company was founded in 2020. Anil Namboodiripad has been the CEO of the company since 2021. | Technology Services |
- Borsa valori
- Insiders
- Anil Namboodiripad
